US Patent No. 9,861,691

NOROVIRUS VACCINE FORMULATIONS


Patent No. 9,861,691
Issue Date January 09, 2018
Title Norovirus Vaccine Formulations
Inventorship Charles Richardson, Bozeman, MT (US)
Thomas S. Vedvick, Federal Way, WA (US)
Thomas R. Foubert, Bozeman, MT (US)
William T. Tino, Belgrade, MT (US)
Assignee Takeda Vaccines, Inc., Cambridge, MA (US)

Claim of US Patent No. 9,861,691

1. A composition comprising two or more Norovirus antigens and a mucoadhesive, wherein at least one of the Norovirus antigens
is from genogroup I and at least one of the Norovirus antigens is from genogroup II, and wherein the amount of each of the
two or more Norovirus antigens is from about 1 ?g to about 100 ?g per dose.